{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "exchange": "STO", "shortName": "OncoZenge AB", "longName": "OncoZenge AB (publ)", "messageBoardId": "finmb_694394254", "market": "se_market", "marketState": "REGULAR", "earningsTimestamp": 1621335540, "earningsTimestampStart": 1621335540, "earningsTimestampEnd": 1621335540, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.88, "epsForward": 2.0, "sharesOutstanding": 11713200, "bookValue": 2.9, "fiftyDayAverage": 7.399, "fiftyDayAverageChange": 0.0009999275, "fiftyDayAverageChangePercent": 0.0001351436, "twoHundredDayAverage": 5.36395, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 2.7777817, "regularMarketPrice": 7.4, "regularMarketChange": 0.20000029, "regularMarketTime": 1684144829, "regularMarketDayHigh": 8.0, "regularMarketDayRange": "7.21 - 8.0", "regularMarketDayLow": 7.21, "regularMarketVolume": 32901, "regularMarketPreviousClose": 7.2, "bid": 7.31, "ask": 7.4, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 7.22, "averageDailyVolume3Month": 60131, "averageDailyVolume10Day": 96283, "fiftyTwoWeekLowChange": 5.29, "fiftyTwoWeekLowChangePercent": 2.5071092, "fiftyTwoWeekRange": "2.11 - 10.56", "fiftyTwoWeekHighChange": -3.1600003, "fiftyTwoWeekHighChangePercent": -0.29924244, "fiftyTwoWeekLow": 2.11, "fiftyTwoWeekHigh": 10.56, "twoHundredDayAverageChange": 2.0360503, "twoHundredDayAverageChangePercent": 0.3795804, "marketCap": 86677680, "forwardPE": 3.7, "priceToBook": 2.5517242, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1613116800000, "priceHint": 2, "symbol": "ONCOZ.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Gustavslundsvagen 34", "city": "Bromma", "zip": "167 51", "country": "Sweden", "phone": "46 8 31 14 20", "website": "https://www.oncozenge.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "OncoZenge AB (publ), a pharmaceutical company, develops treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul  de Potocki M.Sc.", "age": 60, "title": "Chief Exec. Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Beveridge", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Pirkko Sulila Tamsen", "age": 63, "title": "Chief Operating Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Markus  Jerling M.D., Ph.D.", "age": 70, "title": "Chief Medical Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}